Fig. 2.
Study visits and cycles (following Visit 1 – Screening) in a 2019 United States multicenter study evaluating Ovaprene, an investigational vaginal contraceptive.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.